Reuters logo
BRIEF-Ampliphi Biosciences Q1 loss per share $1.94
May 15, 2017 / 8:35 PM / 5 months ago

BRIEF-Ampliphi Biosciences Q1 loss per share $1.94

May 15 (Reuters) - Ampliphi Biosciences Corp

* Ampliphi Biosciences reports first quarter 2017 financial results and provides business highlights

* Q1 loss per share $1.94

* Ampliphi Biosciences Corp - Cash and cash equivalents were $2.2 million as of March 31, 2017, compared with $5.7 million as of December 31, 2016

* Ampliphi Biosciences Corp - Ampliphi recorded a gain for Q1 of 2017 of $114,000 related to change in fair value of derivative liabilities Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below